Journal
INFECTION AND DRUG RESISTANCE
Volume 14, Issue -, Pages 2991-3000Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IDR.S318989
Keywords
MRSA; geraniol; antibacterial activity; inflammatory cytokines; in vivo
Categories
Funding
- National Natural Science Foundation of China [31970137]
- Open Research Subject of Key Laboratory (Research Base) of Food Biotechnology [szjj2015011]
- Sichuan Provincial Department of Education [16ZB0285]
- Scientific Research Fund of Chengdu Medical College [CYZ1502]
- Chunhui Plan of Ministry of Education of China [Z2016120]
- Bidding Project of the Pension and Elderly Health Cooperative Innovation Center of Sichuan province [YLZBZ1806]
- science and technol-ogy project of the health planning committee of Sichuan [19PJ032]
- Sichuan Science and Technology Program [2021YJ0158, 2020JDRC0071]
Ask authors/readers for more resources
Geraniol was found to effectively prevent MRSA infection and showed a significant dose-response relationship in mice. It decreased inflammatory cytokines and oxidative stress factors in infected mice, along with improving histopathological abnormalities. Geraniol has potential as a natural medicine for anti-inflammatory, antioxidant, and antibacterial purposes.
Introduction: Antibiotics wee widely used as feed additives in animal husbandry. With the increase of drug resistance of bacteria, there is an urgent need to find alternatives to antibiotics. Clinically, methicillin-resistant Staphylococcus aureus (MRSA) infections account for about 25% to 50% of Staphylococcus aureus infections worldwide. Similarly, it is also one of the pathogens that cause serious animal infections. Methods: We established a mouse model of systemic infection of MRSA to study the preventive effect of geraniol on MRSA and the immunomodulatory effect of geraniol. The mice in the experiment were injected with geraniol by intramuscular injection and were fed intraperitoneally with minimum lethal dose of MRSA. Then, the survival rate, inflammatory cytokines, oxidative stress factors in serum were measured. These values were used to estimate the bacterial load in different organs and to assess histopathological changes in the lungs, liver and kidneys. Results: The above-mentioned two ways of using geraniol could prevent MRSA infection in vivo in mice and showed a significant dose-response relationship. In other words, geraniol significantly decreased the concentrations of inflammatory cytokines and oxidative stress factors in MRSA-infected mice. At the same time, the level of glutathione peroxidase also increased in a dose-proportional relationship. In the group of mice treated with geraniol, their superoxide dismutase levels were significantly higher than those in the vancomycin. After treatment with geraniol, the burden of MRSA decreased. No obvious histopathological abnormalities were found in the liver and kidney of MRSA-infected mice. In addition, geraniol improved the inflammatory changes in the lungs. Conclusion: The results indicated that geraniol was a natural substance that could be used as an anti-inflammatory, antioxidant and antibacterial substance to protect mice from MRSA systemic infection. Generally, the research shows that as a natural medicine, geraniol has broad potential in the development and application of antibiotic substitutes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available